Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has issued an announcement.
Proteomics International Laboratories Ltd has appointed David Morris as a director effective 19 January 2026, according to an initial director’s interest notice lodged with the ASX. The filing confirms that Morris currently holds no relevant interests in the company’s securities and has no disclosed interests in related contracts, indicating a board-level change without immediate implications for the company’s capital structure or ownership dynamics.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.74 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd is a life sciences company focused on proteomics-based diagnostics and analytical services, operating in the biotechnology and medical research sector with an emphasis on clinical diagnostics and related laboratory technologies.
Average Trading Volume: 451,924
Technical Sentiment Signal: Buy
Current Market Cap: A$131.2M
Find detailed analytics on PIQ stock on TipRanks’ Stock Analysis page.